We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
Cap. Flow
-$218M
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$125M
2
PRGO icon
Perrigo
PRGO
+$103M
3
AGN
Allergan plc
AGN
+$99.6M
4
PFE icon
Pfizer
PFE
+$90M
5
VTRS icon
Viatris
VTRS
+$88.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.63%
2 Healthcare 15.57%
3 Communication Services 13.26%
4 Technology 11.56%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAA
901
DELISTED
CalAtlantic Group, Inc.
CAA
$363K ﹤0.01%
10,851
-801
-7% -$25.1K
MSCC
902
DELISTED
Microsemi Corp
MSCC
$357K ﹤0.01%
+9,313
New +$309K
STLA icon
903
Stellantis
STLA
$16.5B
$356K ﹤0.01%
+44,627
New +$322K
CCC
904
DELISTED
Calgon Carbon Corp
CCC
$344K ﹤0.01%
+24,550
New +$374K
B
905
Barrick Mining
B
$62.2B
$342K ﹤0.01%
25,207
-154,488
-86% -$1.8M
ARLP icon
906
Alliance Resource Partners
ARLP
$3.18B
$340K ﹤0.01%
29,156
-155,678
-84% -$1.9M
NVR icon
907
NVR
NVR
$17.2B
$340K ﹤0.01%
+196
New +$317K
TCP
908
DELISTED
TC Pipelines LP
TCP
$336K ﹤0.01%
+6,970
New +$316K
MTBL
909
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$334K ﹤0.01%
68,013
+12,112
+22% +$57.6K
TRN icon
910
Trinity Industries
TRN
$2.97B
$328K ﹤0.01%
+24,864
New +$349K
CLGX
911
DELISTED
Corelogic, Inc.
CLGX
$327K ﹤0.01%
+9,445
New +$321K
BC icon
912
Brunswick
BC
$5.19B
$313K ﹤0.01%
6,520
-150,210
-96% -$6.5M
MEOH icon
913
Methanex
MEOH
$4.32B
$313K ﹤0.01%
9,734
DWRE
914
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$313K ﹤0.01%
+8,007
New +$311K
SRG
915
Seritage Growth Properties
SRG
$130M
$312K ﹤0.01%
+6,252
New +$260K
WGL
916
DELISTED
Wgl Holdings
WGL
$309K ﹤0.01%
+4,271
New +$286K
CSCD
917
DELISTED
CASCADE MICROTECH, INC.
CSCD
$302K ﹤0.01%
+14,654
New +$272K
OXY icon
918
Occidental Petroleum
OXY
$57B
$300K ﹤0.01%
4,377
-61,089
-93% -$4.09M
FCPT icon
919
Four Corners Property Trust
FCPT
$2.86B
$293K ﹤0.01%
+16,301
New +$273K
GBX icon
920
The Greenbrier Companies
GBX
$1.61B
$293K ﹤0.01%
10,587
-15,141
-59% -$388K
IYR icon
921
iShares US Real Estate ETF
IYR
$4.59B
$293K ﹤0.01%
+3,763
New +$273K
TMHC icon
922
Taylor Morrison
TMHC
$293K ﹤0.01%
20,773
-7,206
-26% -$95.4K
VRTS icon
923
Virtus Investment Partners
VRTS
$1.11B
$293K ﹤0.01%
+3,750
New +$337K
BNFT
924
DELISTED
Benefitfocus, Inc.
BNFT
$287K ﹤0.01%
8,592
-98
-1% -$2.92K
CIE
925
DELISTED
Cobalt International Energy, Inc
CIE
$285K ﹤0.01%
+6,380
New +$304K

Similar funds

Marshall Wace's Q1 2016 Portfolio in Review

As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
  • Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
  • Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
  • Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
  • Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.